Jump to content
  • Sign Up
  • 0

Cannabis Science to file patent for its cannabis processing & drug


grace

Question

Cannabis Science Inc, an emerging pharmaceutical cannabis company, announced that patent filings are expected for two of its key innovations.

 

"The Drug Development Team members recognize the importance of having our first cannabis-based medicine covered, not just by one patent, but by two," Dr Mary J Ruwart, vice president, Research & Development explained. "A competitor can sometimes engineer a way around a single patent. Patenting both the manufacturing process as well as the delivery system virtually guarantees that our product will be immune to 'invasion' by a competing company."

 

Cannabis Science CEO, Steve Kubby, is the inventor who will assign both of his patents to Cannabis Science. "Our new manufacturing process allows for the rapid and uniform harvesting of cannabis 'trichomes,' the part of the plant containing the active ingredient, THC," Kubby told potential investors today. "Just as the cotton gin made cotton harvesting economically feasible, our innovative process will revolutionize trichome harvesting."

 

"Having a creative mind like Steve Kubby's at the helm gives us a competitive advantage," Dr Robert Melamede, chief scientific officer commented. "The new manufacturing process is only the tip of the proverbial iceberg. The unique drug delivery system he has designed enhances the stability and uniform absorption of the active ingredient. We expect our first product to outshine the competition with rapid---and prolonged---blood levels of THC."

 

Cannabis Science management has authorized expenditures for patents; the two described above will be the company's first official filings. "Naturally, Cannabis Science will use both of its discoveries for its own drug production," chief financial officer, Richard Cowan said. "However, other firms will likely want to license these inventions for their own use as well. Cannabis Science will be able to supply other companies with superior trichome preparations or provide our unique drug delivery systems for other pharmaceutical preparations. The entire industry, the American public, and, of course, Cannabis Science and its investors, will reap the benefits."

 

Cannabis Science is at the forefront of medical marijuana research and development. The company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

 

Date: 22 June 2009

Source: Pharmabiz.com

http://www.pharmabiz.com/article/detnews.a...&sectionid=

Link to comment
Share on other sites

1 answer to this question

Recommended Posts

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Answer this question...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using the community in any way you agree to our Terms of Use and We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.